drugset / Trial / NCT04149483

Statin Treatment for UnruptureD Intracranial anEurysms Study

NCT04149483

Phase 2 Unknown 60 enrolled Beijing Neurosurgical Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was designed to identify whether there is a measurable reduction in inflammation in walls of intracranial aneurysms with oral atorvastatin.

Timeline

Start
2019-11-07
Primary completion
2021-02-01
Completion
2021-02-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Atorvastatin Small molecule 20 mg Oral